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Introduction
Coronaviruses (CoVs) infect a number of mammalian species mostly causing respiratory and gastrointestinal tract pathologies (Perlman and Netland, 2009 ). The six human CoVs, namely HCoV-229E, -OC43, -NL63, -HKU1, SARS (severe acute respiratory syndrome)-CoV, MERS (Middle East respiratory syndrome)-CoV are of zoonotic origin (Corman et al., 2018) . The first four viruses mainly target the respiratory tract and are associated with common colds, whereas SARS-and MERS-CoV are highly pathogenic with high mortality rates. (Cui et al., 2019) .
Although great efforts have been made to discover anti-MERS agents by screening defined drug libraries (Cao et al., 2015; de Wilde et al., 2014; Dyall et al., 2014; LaFemina, 2014) no effective drug treatment is available against CoVs.
In order to identify host-targeting agents (HTAs) we have recently performed virus-host protein-protein interaction screenings by testing individual SARS-CoV ORFs against human cDNA libraries utilizing high-throughput yeast-2-hybrid techniques (Pfefferle et al., 2011) . In that study we had identified cyclophilins and FK506-binding (FKBPs) proteins as cellular interaction partners of the viral Nsp1 protein and the cyclophilin-binding immunosuppressive drug cyclosporin A (CsA) as a replication inhibitor of the various human and animal CoVs including SARS-CoV, NL63, 229E and Feline CoV, Transmissible Gastroenteritis Virus, Infectious Bronchitis Virus, respectively. In a follow-up study we found that nonimmunosuppressive CsA derivatives Alisporivir (ALV), NIM811 and further compounds inhibit replication of NL63 and that CypA is an essential cellular molecule required for virus replication (Carbajo-Lozoya et al., 2014) . Similar inhibitory properties of CsA and derivatives on CoV and Arterivirus replication, both belonging to the order of Nidovirales were described (de Wilde et al., 2013a; de Wilde et al., 2013b; de Wilde et al., 2011) .
Here we demonstrate the inhibitory effects of non-immunosuppressive CsA derivatives on 229E replication in various Huh-7-derived hepatoma cell lines and the requirement of CypA for interaction with the viral nucleocapsid protein and for virus propagation in Huh-7.5 cells.
Materials and methods

Western blot antibodies and drugs
Mouse antibody 1H11 (1:20,000) recognizing HCoV-229E N-protein was obtained from INGENASA, Spain (Sastre et al., 2011) . Anti-Lamin A (1:20,000), anti-PPIA (PA1-025) and anti-PPIB (PA1-027A) were purchased from Biomol and ThermoFisher, respectively. Secondary antibodies were received from Biomol (goat anti-rabbit-Ig-horse radish peroxidase HRP, [1:3000] and rabbit-anti-goat-Ig-HRP [1:3000]) and Sigma Aldrich (anti-mouse-Ig-HRP [1:40,000]).
Alisporivir (formerly DEB025) and NIM811 were provided by Novartis (Basel, Switzerland).
CsA and Rapamycin (RAPA) were obtained from Sigma-Aldrich (Germany). Cyclosporin H (CsH) was synthesized according to published procedures (Whitaker and Caspe, 2011) . Synthesis of compound 3 was described recently (Carbajo-Lozoya et al., 2014; Malešević et al., 2013) .
Cell Culture and Cell Lines
Human hepatocellular carcinoma cells Huh-7, Huh-7.5 cells (Blight et al., 2002) and sub clones were maintained in Dulbecco's modified Eagle medium (Invitrogen, Karlsruhe, Germany) supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 1% (v/v) nonessential amino acids, 100 U/ml penicillin, and 100 µg/ml streptomycin. Cells harboring small hairpin RNA (shRNA) were kept in the presence of 5 µg/mL blasticidin. The Huh-7.5-CypA KD cell line (von Hahn et al., 2012) , Huh-7D (Feigelstock et al., 2010) and Huh-7 Lunet (Koutsoudakis et al., 2007) cells were described. Cell viabilities were determined by CellTiter-Glo® Luminescent Cell Viability Assay (Promega #G7570).
Viruses
HCoV-229E viruses expressing Renilla luciferase (LUC) or Green Fluorescent Protein (GFP) (Carbajo-Lozoya et al., 2012; Cervantes-Barragan et al., 2010) reporter genes were used to examine the inhibitory effect of compounds. Generally, Huh-7.5 cells were infected with MOI=0.1 and incubated for two days in the presence of increasing concentrations of inhibitor in the culture medium. Viral replication was determined by measuring Renilla luciferase activity or GFP fluorescence.
Fluorescence microscopy
For evaluation of HCoV-229E-GFP replication in Huh7-derived cell lines cells were split onto sterile coverslips, grown to ~80% confluence and infected with respective MOI. After indicated time points non-infected and infected cells were fixed with 2.5 % formaldehyde for 15 minutes, washed twice with PBS and subjected to DAPI (Cell Signalling) staining. After two further washes coverslips were air-dried, mounted with fluorescence mounting medium (Dako, S3023) and inspected using a Leica DMI 4000IB fluorescence microscope at 40x magnification.
For immunofluorescence analysis, Huh7 cells were seeded onto sterile cover slips in a 24-well plate (Costar) at a cell density of 10 5 cells per well. After 24 hours, cells were infected with HCoV-229E wt at an MOI of 1 for 1.5 h at 37° C and 5% CO 2 . After infection cells were washed with PBS and incubated with CsA, ALV (20 µM) inhibitors and with ethanol as solvent control in the culture medium. For immunostaining, cells were fixed overnight with 4% paraformaldehyde at 4°C. Subsequently, they were blocked with 5% BSA in PBS (Gibco-Life Technologies) overnight. Fixed cells were incubated for 72 h at 4 0 C with the following primary antibodies diluted in PBS (5% BSA, 0.2% Tween-20): mouse anti-dsRNA (clone J2, 1:1,500; Scicons), rabbit anti-CypA (ab3563, 1:500; Abcam), rabbit anti-CypB (1:800; Thermofisher, PA1-027A, mouse anti-PDI (1:100; ThermoFisher, MA3-019), anti-GM130 (1:100, BD Biosciences, 610822), mouse anti-SQSTM1 (1:200; Thermofisher, MA-5-27800), mouse anti-DCP1 (1:500, SantaCruz, sc100706), mouse anti-PABP (1:1500; Sigma Aldrich, P6246). After incubation cells were washed three times with PBS and incubated for one hour in the dark with secondary antibodies goat anti-rabbit-FITC (1:1000; Sigma Aldrich, F0382) and goat antimouse-Alexa-555, 1:500; ThermoFisher, A21424) in PBS containing 5% goat serum and 0.2% Tween-20) at room temperature. Cells were washed with PBS (3x). Cell nuclei were stained with 1 µg/m1 DAPI (Sigma Aldrich, D9542) for 10 min in the dark. After further three washes with PBS coverslips were air-dried, mounted with fluorescence mounting medium (Dako, S3023), and inspected using a Leica DMI 4000IB fluorescence microscope at 40x magnification.
Western blotting
N-protein expression in the presence of inhibitors or in Huh-7.5 CypA variants was analysed as described recently (Carbajo-Lozoya et al., 2014) . Briefly, Huh-7.5 cells were infected at HCoV-229E-LUC/-GFP virus MOI= 0.1 for one hour in six-well plates. Virus was washed off with PBS and inhibitors were added to the medium at the respective concentrations. After 48 hrs cells were harvested and lysed with 250 µl lysis buffer (1 % NP-40 in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM DTT and Protease Inhibitor Cocktail [Hoffmann La Roche]).
Proteins were separated by 8 or 12.5% SDS-PAGE and electro-blotted onto nitrocellulose membranes. Latter were blocked with 5% milk powder in TBST buffer. Primary antibodies were usually incubated at 4 0 C overnight. Secondary antibody incubation was performed at room temperature for two hours. After each incubation step membranes were washed three times with TBST for 10 min. HRP was developed with Immobilon Western blot HRP chemiluminiscent substrate from Millipore. Membranes were exposed to X-ray film (Agfa).
Split YFP protein-protein interaction assay
Construction of split YFP vectors was described recently (Ma-Lauer et al., 2016) . Briefly, pDEST-c-myc-YFP N (c-myc-YFP N [amino acids 1-155] fused to N-terminus of a test gene) and
pDEST-HA-YFP c (HA-YFP C [amino acids (YFP C -229E-"N"), "empty" split YFP vectors or combinations thereof were co-transfected into cells at 80% confluence by using Lipofectamine 3000 (Thermofisher). 24 hours after transfection, cells on coverslips were examined directly under a microscope (Leica DM4000 B).
Pictures were taken with a 40x objective.
Results
HCoV229E grows in different Huh-7-derived cell lines
Human hepatocellular carcinoma cells (Huh-7) support the replication of a number of viruses including HCV (Bartenschlager and Pietschmann, 2005) , HCoV-229E, SARS-CoV and MERS-CoV (Raj et al., 2013) . A number of Huh-7 mutant cell lines [Huh-7.5 (Blight et al., 2002) ,
Huh-7D (Feigelstock et al., 2010) , Huh-7-Lunet (Friebe et al., 2005) ] were generated in order to 
Non-immunosuppressive CsA derivatives inhibit HCoV-229E replication
We have recently reported on the biochemical and immunological characteristics and on the Table 1 . It is clearly demonstrated that similarly to CsA the non-immunosuppressive molecules ALV, NIM811 ( Figure 1A ) and
compound 3 ( Figure 1B ) inhibit 229E-LUC replication in the low micromolar range. Cell viability was only slightly affected at highest concentrations used. As control we included CsH and Rapamycin.
CsH is a stereoisomer of CsA in which D-methylvaline at position 11 substitutes the natural Lmethylvaline. Following the minor affinity for CypA this substitution abrogates the immunosuppressive and anti-inflammatory properties of CsA (de Paulis et al., 1996; LeGrue et al., 1986) . Figure 1C shows a slight residual inhibitory activity of the CsH preparation, which might be a result of the low CypA affinity or of traces of CsA-like impurities present in the CsH preparation. Due to the chemical similarity (stereoisomers) of these molecules, the impurities are very difficult to remove from the product batches. We also observed a very low inhibition of CypA in the PPIase assay with this compound. The immunosuppressive drug rapamycin was used as a further, cyclophilin-independent control molecule to test the effect of immunosuppressants on CoV replication. It binds to FKBP1A (=FKBP12), but as opposed to FK506 it interferes with the mTOR (mechanistic Target of Rapamycin) pathway by inhibiting a serine/threonine protein kinase (Huang et al., 2003) . Figure 1B shows background inhibitory activity of rapamycin. Thus, lack of effective inhibition of viral replication by CsH, which does not affect the PPIAse activities of cyclophilins strongly, argues for the requirement of this function for coronavirus replication.
Effects of inhibitory drugs on HCoV-229E N protein expression
The N protein is a multifunctional protein (McBride et al., 2014) and it is required for virus replication and for the propagation of replicons (Chang et al., 2014) . Its primary function is to 
CsA and non-immunosuppressive derivatives inhibit binding of HCoV-229E-N protein to
CypA As SARS-CoV N protein was reported to bind CypA in vitro (Luo, et al. 2004 ), we tested whether HCoV-229E N protein binds directly to CypA by split YFP interaction experiments in living HEK293 cells. The experimental protein-protein interaction system has been described recently (Ma-Lauer et al., 2016) . It is based on the splitting of YFP into N (YFP N )-and C (YFP C )-terminal halves which are fused at the DNA level to two proteins to be tested for interaction. Upon interaction of the two proteins, the two YFP fragments assemble to functional YFP, which is demonstrated by fluorescence. Fig. 3 Quite interestingly, from our earlier Y2H interaction studies we had hints on the interaction between CypA and the SARS-CoV X-domain also called macrodomain I (Mac1) (Lei et al., 2018; Pfefferle et al., 2011) . Here (right panel of Fig. 3) we also found interaction of CypA (PPIA-YFP N ) with the X-domain of HCoV-229E (229E-X-dom-YFP C ). However, CsA, ALV or NIM811 did not block this interaction. As CypB might also be an important player during virus replication, we applied analogous setups used for CypA for testing possible interaction of CypB with HCoV-229E-N proteins. As shown in Fig. 3 (lower panel) we could not demonstrated interaction irrespective of the orientation of the split YFP fusion proteins.
Localization and expression of CypB but not of CypA is strongly altered by HCoV-229E and cyclophilin inhibitors
CsA and ALV block the activity of both cyclophilins A/B. So far, the inhibitory effect on
HCoV-229E replication cannot exclusively be attributed to only one or to both cyclophilins. We reasoned that a possible co-localization of the cyclophilins with a marker of viral replication at the site of replication might give hints on the relevance of the two proteins. Therefore, we visualized the effect of both inhibitors on the intracellular localization of CypA/B and dsRNA by immunofluorescence assays in presence and absence of virus. Expression levels of CypA were similar, and it was distributed throughout cytoplasm and nucleus of Huh7 cells irrespective of the conditions (Fig. 4 , "anti-CypA column"). In contrast, CypB located in untreated cells (no inhibitors and no virus) almost exclusively to the cytoplasm (Fig. 5 , "ETOH/mock" and "ETOH/HCoV-229E" panels). From earlier work, it is known that CsA alters CypB trafficking through the secretory pathway (Price et al., 1994) . Here we found that CypB Inhibitor treatment causes its re-localization and sequestration to foci in the nucleus and a strong reduction of expression ( Fig. 5, right Due to the intense concentration, we refer to virus-induced CypB/ER blebs. Staining with antibodies against other cell organelles (cis-Golgi, autophagosomes, P-bodies, stress granules) did not reveal co-localization with CypB (Fig. 6 ). Viral dsRNA did co-localize neither with CypA ( Fig. 4 , "ETOH/HCoV-229E" row) nor with CypB/ER blebs (Fig. 5 , "ETOH/HCoV-229E" row). These blebs were not observed in infected and CsA/ALV-treated cells as the inhibitors prevent virus replication. Western blot analysis clearly demonstrated down-regulation of CypB but not of CypA in the presence of inhibitors independent of virus infection in Huh7 cells (Fig. 7) .
Discussion
In a recent study we had identified CsA as a broad-spectrum inhibitor of CoV replication in humans, mouse, cat, pig and bird with cyclophilins as presumable cellular targets ( Cyclophilins are ubiquitous enzymes catalyzing the cis/trans isomerization of prolyl peptide bonds (PPIase activity) thus facilitating protein folding (Lang et al., 1987) . The most prominent human cyclophilin is CypA with important roles in many biological processes such as protein folding and trafficking (Nigro et al., 2013) . In addition, the coincidental binding of the CsA/CypA complex causes immunosuppression, i.e. it prevents activation of the transcriptional regulator Nuclear Factor of Activated T-cells. Inhibition of the PPIase activity not only prevents correct folding of cellular, but also of a number of viral proteins indispensable for viral replication. This was first shown for Human Immunodeficiency Virus 1 (HIV-1) and Hepatitis C virus (HCV) (Hopkins and Gallay, 2014; Lin and Gallay, 2013) . Thus, cyclophilins are discussed as therapeutic targets of viral liver diseases (Naoumov, 2014) . inhibition experiments (Fig. 1, Table 1 ) clearly demonstrate the highly effective inhibition of the Renilla luciferase-expressing 229E-LUC with decreasing EC 50 values between 18 and 48 hours p.I. Inhibition patterns of ALV, NIM811 (both Fig. 1A) , compounds 3 ( Fig. 1B) and CsA (Fig. 1C) In an earlier report we had described 229E inhibition by the FKBP-binding drug FK506 We attribute the reason for the downregulation of N expression in the presence of Cyp inhibitors to the prevention of the interaction of N and CypA. The split YFP protein-protein interaction experiments clearly show the interaction of the two proteins in HEK293 cells and its abolishment in the presence of the inhibitors (Fig. 3) . Another viral protein, the X-domain of Nsp3, also interacts with CypA. Cyp inhibitors do not prevent this interaction, suggesting different mechanisms. We can only speculate that different binding sites, chemical bonds or different time points of interaction of CypA with viral proteins might be involved during viral replication.
CsA and its non-immunosuppressive derivatives inhibit replication of a number of viruses including HCV, HBV and HIV-1. In most cases the responsible cyclophilin is CypA (Zhou et al., 2012) . CypA and CypB were found to be required for FCoV replication (Tanaka et al., 2016) . For HCoV-NL63, we have recently shown that CypA expression is essential in CaCo-2 cells (Carbajo-Lozoya et al., 2014) . Utilizing a Huh-7.5 CypA KD (knockdown) cell line, originally constructed for the study of the requirement of stable CypA for HCV replication (von Hahn et al., 2012) we found significantly reduced replication of a HCoV-229E-Renilla luciferase expressing virus (von Brunn et al., 2015) . This indicates the involvement of CypA also in replication of HCoV-229E.
Minor replicative activity might be explained by an incomplete suppression of CypA in the shRNA-based knockdown, as the protein is one of the most abundant proteins (~0.1-0.4% of total cellular protein) in the cell cytoplasm (Fischer and Aumuller, 2003; Saphire et al., 2000) . CypA-negative by Western blot with an antibody directed against a short peptide sequence at the C-terminus of CypA. However, this region is located within exon 5 and it cannot be excluded that frameshifts occurred upstream of the antibody-recognized peptide sequence within exon 5, which was not sequenced. Interestingly, it was not possible to generate Huh7-CypB KO , Huh7-CypC KO , and Huh7-CypD KO cell clones.
Residual molecules of
We have shown earlier that SARS-CoV Nsp1 protein binds to cyclophilins. The binding of
CypA to the SARS-CoV N protein is known from a very early educated guess finding using surface plasmon resonance biosensor technology (Luo et al., 2004) . This was supported by a spectrometric profiling study showing the incorporation of CypA into SARS-CoV virions (Neuman et al., 2008) . Here we show for the first time the direct interaction between CypA and HCoV-229E "N" protein and "X" (ADRP) proteins by split YFP assay (Fig. 3) . Most interestingly, only the CypA-"N" but not the CypA-"X" interaction is blocked by CsA and non- hrs and samples were processed for IF. CypB and dsRNA were stained with anti-CypB (green) and anti-dsRNA J2 (red, Scicons, 1:1500), respectively. Nuclei were visualized with DAPI.
CypB shifts from an even cytoplasmic distribution to intense bleb-like structures in the presence of virus (white arrows, ETOH solvent panels). CsA and ALV led to the re-localization of CypB to granular structures in the nucleus and to a massive reduction of expression independent of virus infection. dsRNA as replication marker was not detected in the presence of CsA or ALV. Exposure times for the respective antibodies were the same in the different samples. 
Legend Supplemental Fig. 2:
Chemical structure of compound 3.
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